Evidence map›Paper›PMID 32678314›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2020

A quality improvement initiative to implement the eat, sleep, console neonatal opioid withdrawal syndrome care tool in Massachusetts' PNQIN collaborative.

Elisha M Wachman, Mary Houghton, Patrice Melvin, Breanna C Isley, Jennifer Murzycki, Rachana Singh, Susan Minear, Kathryn Dee L MacMillan, Debra Banville, Amy Walker and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Neonatal Opioid Withdrawal Syndrome: 2 Years Later…Where Are We NOWS?The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Short term outcomes of neonatal opioid withdrawal syndrome: a comparison of two approaches.Journal of perinatology : official journal of the California Perinatal Association · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Is Eat, Sleep, Console the New Standard of Care?The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2023
    Article
  17. Review
  18. Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants.Journal of perinatology : official journal of the California Perinatal Association · 2022
    Review
  19. Article
  20. Leveraging the Massachusetts perinatal quality collaborative to address the COVID-19 pandemic among diverse populations.Journal of perinatology : official journal of the California Perinatal Association · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 13 institutions in 1 country.

Elisha M WachmanDepartment of Pediatrics, Boston Medical Center, Boston, MA, USA. Elisha.Wachman@bmc.org.ORCID http://orcid.org/0000-0002-6307-6999
Mary HoughtonNewborn Medicine, Beth Israel Deaconness Medical Center, Boston, MA, USA.
Patrice MelvinCenter for Applied Pediatric Quality Analytics, Children's Hospital Boston, Boston, MA, USA.
Breanna C IsleyDepartment of Pediatrics, Boston Medical Center, Boston, MA, USA.
Jennifer MurzyckiDepartment of Pediatrics, Lowell General Hospital, Boston, MA, USA.
Rachana SinghDepartment of Pediatrics, Baystate Children's Hospital, Springfield, MA, USA.
Susan MinearDepartment of Pediatrics, Boston Medical Center, Boston, MA, USA.
Kathryn Dee L MacMillanDepartment of Pediatrics, MassGeneral Hospital for Children, Boston, MA, USA.
Debra BanvilleSouth Shore Hospital, Weymouth, MA, USA.
Amy WalkerCooley Dickinson Hospital, Northampton, MA, USA.
Teresa MitchellDepartment of Pediatrics, Mercy Medical Center, Springfield, MA, USA.
Rose Galimi-HayesMilford Regional Medical Center, Milford, MA, USA.ORCID http://orcid.org/0000-0003-0758-251X
Selena JorgensenDivision of Newborn Medicine, Boston Children's Hospital, Boston, MA, USA.
Daphne Remy GomesDepartment of Neonatology, Boston Children's Hospital, Boston, MA, USA.
Fran HodginsMassachusetts Health Policy Commission, Boston, MA, USA.
Bonny L WhalenDepartment of Pediatrics, Children's Hospital at Dartmouth-Hitchcock, Lebanon, NH, USA.
Hafsatou DiopMassachusetts Department of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0002-3654-9674
Munish GuptaNewborn Medicine, Beth Israel Deaconness Medical Center, Boston, MA, USA.
Boston Children's Hospital · USBoston Medical Center · USBeth Israel Deaconess Medical Center · USBaystate Medical Center · USBoston Public Health Commission · USChildren's Hospital at Dartmouth Hitchcock · USCooley Dickinson Health Care · USLowell General Hospital · USMassachusetts Department of Public Health · USMassachusetts General Hospital · USMercy Medical Center · USRegional Medical Center · USSouth Shore Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo support hospitals in the Massachusetts PNQIN collaborative with adoption of the ESC Neonatal Opioid Withdrawal Syndrome (NOWS) Care Tool© and assess NOWS hospitalization outcomes. STUDY

designStatewide QI study where 11 hospitals adopted the ESC NOWS Care Tool©. Outcomes of pharmacotherapy and length of hospital stay (LOS) and were compared in Pre- and Post-ESC implementation cohorts. Statistical Process Control (SPC) charts were used to examine changes over time.

resultsThe Post-ESC group had lower rates of pharmacotherapy (OR 0.35, 95% CI 0.26, 0.46) with shorter LOS (RR 0.79, 95% CI 0.76, 0.82). The 30-day NOWS readmission rate was 1.2% in the Pre- and 0.4% in the Post-ESC cohort. SPC charts indicate a shift in pharmacotherapy from 54.8 to 35.0% and LOS from 14.2 to 10.9 days Post-ESC.

conclusionsThe ESC NOWS Care Tool was successfully implemented across a state collaborative with improvement in NOWS outcomes without short-term adverse effects.

Indexed as

Analgesics, OpioidNeonatal Abstinence SyndromeHumansInfant, NewbornLength of StayQuality ImprovementSleepAnalgesics, Opioid

Identifiers

PMID32678314
OpenAlexW3043337514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.